These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 7623879)
1. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. Pallares R; Liñares J; Vadillo M; Cabellos C; Manresa F; Viladrich PF; Martin R; Gudiol F N Engl J Med; 1995 Aug; 333(8):474-80. PubMed ID: 7623879 [TBL] [Abstract][Full Text] [Related]
2. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains? Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226 [TBL] [Abstract][Full Text] [Related]
3. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. Pallares R; Gudiol F; Liñares J; Ariza J; Rufi G; Murgui L; Dorca J; Viladrich PF N Engl J Med; 1987 Jul; 317(1):18-22. PubMed ID: 3587309 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T; Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand. Reechaipichitkul W; Assawasanti K; Chaimanee P Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993 [TBL] [Abstract][Full Text] [Related]
6. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia]. Sánchez C; Armengol R; Mir I; Lite J; Garau J Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015 [TBL] [Abstract][Full Text] [Related]
7. Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Martínez E; Miró JM; Almirante B; Aguado JM; Fernandez-Viladrich P; Fernandez-Guerrero ML; Villanueva JL; Dronda F; Moreno-Torrico A; Montejo M; Llinares P; Gatell JM; Clin Infect Dis; 2002 Jul; 35(2):130-9. PubMed ID: 12087518 [TBL] [Abstract][Full Text] [Related]
8. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A; Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620 [TBL] [Abstract][Full Text] [Related]
11. Treatment of pneumococcal pneumonia. Pallares R Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315 [TBL] [Abstract][Full Text] [Related]
12. [Current use of penicillin in community-acquired pneumococcal pneumonias]. Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for pneumococcal pneumonia in Turkey. Oncu S; Erdem H; Pahsa A Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975 [TBL] [Abstract][Full Text] [Related]
14. [Endocarditis due to penicillin-sensitive and -resistant pneumococci: the current perspectives on the disease]. Aguado JM; Casillas A; Lizasoaín M; Lumbreras C; Peña C; Martín-Durán R; Fernández-Viladrich P; Fernández-Guerrero ML; Noriega AR Med Clin (Barc); 1993 Mar; 100(9):325-8. PubMed ID: 8455409 [TBL] [Abstract][Full Text] [Related]
15. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R; J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376 [TBL] [Abstract][Full Text] [Related]
17. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850 [TBL] [Abstract][Full Text] [Related]
18. Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap? Wiener-Well Y; Raveh D; Schlesinger Y; Yinnon AM; Rudensky B Chemotherapy; 2009; 55(2):97-104. PubMed ID: 19145079 [TBL] [Abstract][Full Text] [Related]
19. A surveillance study on penicillin-resistant streptococcus pneumoniae in China. Li J; Zhang Y; Lu Y; Chen Y; Liu J; Chen Y; Hao F; Xue F Chin Med J (Engl); 1999 Jul; 112(7):655-8. PubMed ID: 11601264 [TBL] [Abstract][Full Text] [Related]
20. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients. Gentile JH; Sparo MD; Mercapide ME; Luna CM Medicina (B Aires); 2003; 63(1):9-14. PubMed ID: 12673954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]